SCHEMBL28303699

SCHEMBL28303699

O=C(Cc1ccccc1)N1CCCC1c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.59
RIPK1 Q13546 1/20 0.58
ALDH1A1 P00352 4/20 0.57
POLB P06746 1/20 0.57
PPID Q08752 1/20 0.55
MC4R P32245 2/20 0.52
MC3R P41968 2/20 0.52
MC1R Q01726 2/20 0.52
AADAT Q8N5Z0 2/20 0.52
HSP90AA1 P07900 1/20 0.51
HSP90AB1 P08238 1/20 0.51
KDM4E B2RXH2 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
GLA P06280 1/20 0.50
HPGD P15428 1/20 0.50
SCD O00767 2/20 0.49
HSD11B1 P28845 1/20 0.49
ADAM17 P78536 1/20 0.48
SCD5 Q86SK9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13370801 1.00 EPHX2 (0.59) EPHX2RIPK1ALDH1A1POLBPPID
SCHEMBL2038120 1.00 EPHX2 (0.59) EPHX2RIPK1ALDH1A1POLBPPID
SCHEMBL28005101 0.95 ALDH1A1 (0.56) EPHX2RIPK1ALDH1A1POLBPPID
SCHEMBL25884649 0.85 EPHX2 (0.63) EPHX2RIPK1POLBPPIDHSP90AA1
SCHEMBL12964250 0.83 RIPK1 (0.64) EPHX2RIPK1PPIDHSP90AA1HSP90AB1
SCHEMBL1779437 0.83 HDAC1 (0.53) EPHX2PPID
SCHEMBL8004499 0.83 HDAC1 (0.53) EPHX2PPID
Hydrochloric Acid SCHEMBL27412469 0.82 RIPK1 (0.62) EPHX2RIPK1PPIDHSP90AA1HSP90AB1
SCHEMBL1780619 0.81 GPR183 (0.47) EPHX2RIPK1PPIDAADAT
SCHEMBL24264808 0.81 RIPK1 (0.61) EPHX2RIPK1PPIDHSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110036009-A Substituted pyrrolidines and their use in the treatment of cystic fibrosis 艾伯维公司 2019-07-19 CN disclosed